← Back to Search

Standard of Care + Vielight RX Plus Treatment for Coronavirus (COVIDLight Trial)

N/A
Waitlist Available
Research Sponsored by Vielight Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

This trial will test if the Vielight RX Plus can help speed up recovery for people with COVID-19 and if it can help reduce the severity of the viral infection.

Eligible Conditions
  • Coronavirus

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Standard of Care + Vielight RX Plus TreatmentExperimental Treatment1 Intervention
The is group will receive Vielight RX Plus treatment and follow the COVID-19 standard of treatment recommended by Health Canada.
Group II: Standard of CareActive Control1 Intervention
This group will not receive Vielight RX Plus treatment. Instead, they will follow the COVID-19 standard of treatment recommended by Health Canada.

Find a Location

Who is running the clinical trial?

Vielight Inc.Lead Sponsor
4 Previous Clinical Trials
344 Total Patients Enrolled
~57 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top